Social Pulse: Abiomed Inc (ABMD.O)
ABMD.O on Nasdaq
19 Dec 2014
19 Dec 2014
Price Change (% chg)
- Update: Abiomed's Q2 Fiscal 2015 Earnings Remained Impressive
- Abiomed (ABMD) Upgraded From Hold to Buy
- ABIOMED's (ABMD) CEO Mike Minogue on Q2 2015 Results - Earnings Call Transcript
- ABIOMED (ABMD) Q2 2015 Results - Earnings Call Webcast
- Update: Abiomed Announces Clinical Trial Results For Impella RP
- Abiomed's (ABMD) CEO Michael Minogue on Q1 2015 Results - Earnings Call Transcript
- Glancy Binkow & Goldberg LLP Announces Lead Plaintiff Deadline in the Class Action Lawsuit AgainstAbiomed, Inc.
- Law Offices of Howard G. Smith Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against Abiomed, Inc.
- Investor Alert: Following Food and Drug Administration Panel Vote, Hagens Berman Reminds Abiomed, Inc. Investors of Jan. 15, 2013, Lead Plaintiff Deadline in Class-Action Lawsuit
- FDA 515i Reclassification Panel Recommends Class III Status for Temporary Ventricular Support Devices in the Non-Roller Type Cardiopulmonary Bypass Blood Pumps Category
- Milberg LLP Announces Pendency of Class Action Lawsuits Filed Against Abiomed, Inc. (ABMD) -- AbiomedLawsuit.com